Distinct methylation patterns in genes that affect mitochondrial function are associated with kidney disease in blood-derived DNA from individuals with Type 1 diabetes

Diabetic Medicine

Volumn 32, Issue 8, 2015, Pages 1110-1115

  Swan, E J ^a   Maxwell, A P ^a,b   Mcknight, A J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MITOCHONDRIAL PROTEIN; PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE 1; MITOCHONDRIAL DNA;

ADULT; ARTICLE; CASE CONTROL STUDY; CHROMOSOME 3P; CONTROLLED STUDY; CPG ISLAND; DIABETIC NEPHROPATHY; DNA METHYLATION; END STAGE RENAL DISEASE; EPIGENETICS; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MITOCHONDRIAL GENE; MITOCHONDRION; PHENOTYPE; QUALITY CONTROL; SINGLE NUCLEOTIDE POLYMORPHISM; X CHROMOSOME; COMPLICATION; DIABETIC NEPHROPATHIES; GENETIC EPIGENESIS; GENETICS; KIDNEY FAILURE, CHRONIC; METABOLISM; RENAL INSUFFICIENCY, CHRONIC;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DNA METHYLATION; DNA, MITOCHONDRIAL; EPIGENESIS, GENETIC; GENES, MITOCHONDRIAL; HUMANS; KIDNEY FAILURE, CHRONIC; MITOCHONDRIA; RENAL INSUFFICIENCY, CHRONIC;

EID: 84948712319     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12775     Document Type: Article

References (24)

1. Gilg J, Rao A, Fogarty D. UK Renal Registry 16th Annual Report: Chapter 1 UK renal replacement therapy incidence in 2012: national and centre-specific analyses. Nephron Clin Pract 2013; 125: 1-27.
2. Najafian B, Alpers CE, Fogo AB. Pathology of human diabetic nephropathy. Contrib Nephrol 2011; 170: 36-47.
3. Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev 2013; 93: 137-188.
4. McKnight AJ, McKay GJ, Maxwell AP. Genetic and epigenetic risk factors for diabetic kidney disease. Adv Chronic Kidney Dis 2014; 21: 287-296.
5. Ko YA, Mohtat D, Suzuki M, Park AS, Izquierdo MC, Han SY et al. Cytosine methylation changes in enhancer regions of core pro-fibrotic genes characterize kidney fibrosis development. Genome Biol 2013; 14: R108.
6. Smyth LJ, McKay GJ, Maxwell AP, McKnight AJ. DNA hypermethylation and DNA hypomethylation is present at different loci in chronic kidney disease. Epigenetics 2014; 9: 366-376.
7. Witasp A, Ekstrom TJ, Lindholm B, Stenvinkel P, Schalling M, Nordfors L. Novel insights from genetic and epigenetic studies in understanding the complex uraemic phenotype. Nephrol Dial Transplant 2014; 29: 964-971.
8. Infantino V, Castegna A, Iacobazzi F, Spera I, Scala I, Andria G et al. Impairment of methyl cycle affects mitochondrial methyl availability and glutathione level in Down's syndrome. Mol Genet Metab 2011; 102: 378-382.
9. Berthier A, Jimenez-Sainz J, Pulido R. PINK1 regulates histone H3 trimethylation and gene expression by interaction with the polycomb protein EED/WAIT1. Proc Natl Acad Sci USA 2013; 110: 14729-14734.
10. Iacobazzi V, Castegna A, Infantino V, Andria G. Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. Mol Genet Metab 2013; 110: 25-34.
11. Wang HN, Chen HD, Chen KY, Xiao JF, He K, Xiang GA et al. Highly expressed MT-ND3 positively associated with histological severity of hepatic steatosis. APMIS 2014; 122: 443-451.
12. Pirola CJ, Gianotti TF, Burgueno AL, Rey-Funes M, Loidl CF, Mallardi P et al. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease. Gut 2013; 62: 1356-1363.
13. Sandholm N, Salem RM, McKnight AJ, Brennan EP, Forsblom C, Isakova T et al. New susceptibility loci associated with kidney disease in type 1 diabetes. PLoS Genet 2012; 8: e1002921.
14. Bell CG, Teschendorff AE, Rakyan VK, Maxwell AP, Beck S, Savage DA. Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med Genomics 2010; 3: 33.
15. Houseman EA, Accomando WP, Koestler DC, Christensen BC, Marsit CJ, Nelson HH et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 2012; 13: 86.
16. Gray KA, Daugherty LC, Gordon SM, Seal RL, Wright MW, Bruford EA. Genenames.org: the HGNC resources in 2013. Nucleic Acids Res 2013; 41(Database issue): D545-D552.
17. Miao F, Chen Z, Genuth S, Paterson A, Zhang L, Wu X et al. Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes. Diabetes 2014; 63: 1748-1762.
18. Reddy MA, Sumanth P, Lanting L, Yuan H, Wang M, Mar D et al. Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice. Kidney Int 2014; 85: 362-373.
19. Richman TR, Davies SM, Shearwood AM, Ermer JA, Scott LH, Hibbs ME et al. A bifunctional protein regulates mitochondrial protein synthesis. Nucleic Acids Res 2014; 42: 5483-5494.
20. Chowdhury S, Erickson SW, MacLeod SL, Cleves MA, Hu P, Karim MA et al. Maternal genome-wide DNA methylation patterns and congenital heart defects. PLoS One 2011; 6: e16506.
21. Harris RA, Nagy-Szakal D, Pedersen N, Opekun A, Bronsky J, Munkholm P et al. Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases. Inflamm Bowel Dis 2012; 18: 2334-2341.
22. Wang L, Aakre JA, Jiang R, Marks RS, Wu Y, Chen J et al. Methylation markers for small cell lung cancer in peripheral blood leukocyte DNA. J Thorac Oncol 2010; 5: 778-785.
23. Zhu Y, Stevens RG, Hoffman AE, Tjonneland A, Vogel UB, Zheng T et al. Epigenetic impact of long-term shiftwork: pilot evidence from circadian genes and whole-genome methylation analysis. Chronobiol Int 2011; 28: 852-861.
24. Swan EJ, Salem RM, Sandholm N, Tarnow L, Rossing P, Lajer M et al. Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetes. Diabet Med 2015; 32: 1104-1109.